急性期用脳室ドレーンの市場規模、シェア、動向分析レポート：用途別（外傷性脳損傷（TBI）、くも膜下出血、脳内出血）、患者タイプ別、地域別、セグメント別予測、2022年～2030年

急性期用脳室ドレーン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の急性期用脳室ドレーン市場規模は2030年までに4億3269万米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR7.91%で拡大すると予測されています。従来の方法よりも従来型の採用の増加、急性水頭症の有病率の増加、急性期用脳室ドレーンのための技術的に進んだデバイスの採用の増加が、予測期間中の業界の成長を促進しています。

EVDは、急性水頭症の治療にメリットをもたらします。水頭症は、過剰なCSFを排出するために、脳の側脳室のいずれかにEVDを設置する必要がある医学的緊急事態です。毎年、LMICsでは74万件、HICsでは約3万件の水頭症が発生し、脳神経外科手術が必要とされています。同様に、水頭症協会によると、水頭症は約100万人のアメリカ人が罹患しています。

乳児の後天性水頭症の原因としては脳室内出血が最も多く、EVDによる早期介入（生後25日以内）が神経学的な結果を改善することが研究で示されています。EVDは上記のような疾患において最も多く使用されているため、これらの要因が業界に直接影響を与えています。

さらに、助成金の配分や承認、脳損傷後の患者の回復を助ける最も効果的なケアや治療法を特定するための投資など、政府の取り組みが各国で実施されています。水頭症協会によると、2021年には研究に約1200万米ドルが投資され、さらにカナダでは水頭症疾患のケアの研究と開発のために3500万米ドルの連邦資金が提供されました。

さらに、2022年4月には、水頭症の乳児の脳脊髄液を評価する新しい方法を探るため、研究者に285万米ドルのNIH助成金が支給されました。前述の要因の結果、近い将来、市場は大幅に増加することが予測されます。

急性期用脳室ドレーン市場レポートハイライト

用途別では、2021年に外傷性脳損傷（TBI）が33.78%の最大の売上シェアを占めました。これは、世界の手術件数の増加とともに、TBIの有病率が増加しているためです

患者タイプ別に見ると、小児患者タイプは、新生児の水頭症を治療するための外科手術数の増加により、2022年から2030年にかけて最も速いCAGR8.02％で成長すると予測されます。例えば、Pediatric Neurosurgeryによると、米国では毎年約69,000人の水頭症患者の退院が報告されています。

アジア太平洋地域の急性期用脳室ドレーン市場は、予測期間中に8.26%という最速のCAGRを記録すると予想されます。これは、先進国および新興国における主要プレイヤーの認知度向上と投資の増加によるもので、予測期間中の著しい成長率の主な要因の1つとなっています。

業界は、Medtronic、Integra LifeSciences Corporation、Natus Medical Incorporated、Fuji Systems、Spiegelberg GmbH、SOPHYSA、Neuromedexなどのプレイヤーにより、非常に競争が激しくなっています。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • 応用
  • 患者タイプ
  • 地域範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース：
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析（モデル1）
    • アプローチ1：コモディティフローアプローチ
  • 出来高価格分析（モデル2）
    • アプローチ2：出来高分析
• 二次情報一覧
• 一次情報のリスト
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 急性期用脳室ドレーン市場の変数、動向、範囲

• 市場系列の見通し
  • 親市場の見通し
  • アンシラリー市場の見通し
• 浸透と成長の見通しのマッピング
• ユーザー視点分析
  • 消費者行動分析
  • 市場インフルエンサー分析
• 主要なエンドユーザーのリスト
• 市場力学
  • 市場促進要因分析
    • 神経疾患の有病率の増加
    • 交通事故、転倒、スポーツ外傷の負担増
    • 低侵襲脳神経外科手術に対する意識と需要の高まり
    • 技術の進歩
  • 市場抑制要因分析
    • 外部脳室ドレーン別感染症および合併症
    • 熟練した専門家の不足とctスキャナーへのアクセス
  • 市場機会分析
    • コーティングされた体外ドレーンの開発
  • 市場の課題分析
    • EVDの代替品の入手可能性
• 急性期用脳室ドレーン：市場分析ツール
  • 業界分析- ポーターズ
  • 害虫にSWOT分析
• COVID-19の市場への影響とパンデミック後の洞察

第4章 急性期用脳室ドレーン市場：セグメント分析、アプリケーション別、2017年から2030年（100万米ドル）

• 定義と範囲
• アプリケーション市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 2017年から2030年までのアプリケーション別の世界の急性期用脳室ドレーン市場
• 市場規模と予測、トレンド分析、2017年から2030年
  • 外傷性脳損傷
  • くも膜下出血
  • 脳内出血
  • その他の非外傷性水頭症の状態

第5章 急性期用脳室ドレーン市場：セグメント分析、患者タイプ別、2017年～2030年（100万米ドル）

• 定義と範囲
• 患者タイプの市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 2017年から2030年までの患者タイプ別の世界の急性期用脳室ドレーン市場
• 市場規模と予測、トレンド分析、2017年から2030年
  • 小児科
  • 大人

第6章 急性期用脳室ドレーン市場：2017年から2030年までのアプリケーション別および患者タイプ別の地域市場分析（100万米ドル）

• 定義と範囲
• 地域市場シェア分析、2021年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• 2021年から2030年までの市場規模、予測、量および傾向分析
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第7章 急性期用脳室ドレーン市場-競合分析

• 主要な市場参加者別最近の動向と影響分析
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要企業の市場シェア分析、2021年
  • Major Deals And Strategic Alliances
    • 新製品の発売
    • 拡張
    • 取得
  • Market Entry Strategies
• 企業プロファイル
  • MEDTRONIC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • NIPRO CORPORATION
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • INTEGRA LIFESCIENCES CORPORATION
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • NATUS MEDICAL INCORPORATED
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • FUJI SYSTEMS
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SPIEGELBERG GMBH
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SOPHYSA
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • NEUROMEDEX
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 North America acute external ventricular drain market, by country, 2017 - 2030 (USD Million)
• Table 4 North America acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 5 North America acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 6 US acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 7 US acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 8 Canada acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 9 Canada acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 10 Europe acute external ventricular drain market, by country, 2017 - 2030 (USD Million)
• Table 11 Europe acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 12 Europe acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 13 UK acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 14 UK acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 15 Germany acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 16 Germany acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 17 France acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 18 France acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 19 Italy acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 20 Italy acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 21 Spain acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 22 Spain acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 23 Asia Pacific acute external ventricular drain market, by country, 2017 - 2030 (USD Million)
• Table 24 Asia Pacific acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 25 Asia Pacific acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 26 China acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 27 China acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 28 Japan acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 29 Japan acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 30 India acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 31 India acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 32 Australia acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 33 Australia acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 34 South Korea acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 35 South Korea acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 36 Latin America acute external ventricular drain market, by country, 2017 - 2030 (USD Million)
• Table 37 Latin America acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 38 Latin America acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 39 Brazil acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 40 Brazil acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 41 Mexico acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 42 Mexico acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 43 Argentina acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 44 Argentina acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 45 Colombia acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 46 Colombia acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 47 Middle East & Africa acute external ventricular drain market, by country, 2017 - 2030 (USD Million)
• Table 48 Middle East & Africa acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 49 Middle East & Africa acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 50 South Africa acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 51 South Africa acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 52 Saudi Arabia acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 53 Saudi Arabia acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)
• Table 54 UAE acute external ventricular drain market, by application, 2017 - 2030 (USD Million)
• Table 55 UAE acute external ventricular drain market, by patient type, 2017 - 2030 (USD Million)

List of Figures

• Fig. 1 Acute external ventricular drain market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2021)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Acute external ventricular drain market: Application movement analysis
• Fig. 19 Segment dashboard
• Fig. 20 Traumatic brain injury market application outlook: Key takeaways
• Fig. 21 Subarachnoid hemorrhage market, 2017 - 2030 (USD Million)
• Fig. 22 Intracerebral hemorrhage market, 2017 - 2030 (USD Million)
• Fig. 23 Other non-traumatic hydrocephalus conditions market, 2017 - 2030 (USD Million)
• Fig. 24 Acute external ventricular drain market: Patient type movement analysis
• Fig. 25 Segment dashboard
• Fig. 26 Acute external ventricular drain market patient type outlook: Key takeaways
• Fig. 27 Pediatric market, 2017 - 2030 (USD Million)
• Fig. 28 Adult market, 2017 - 2030 (USD Million)
• Fig. 29 Regional outlook, 2021 & 2030
• Fig. 30 Regional market dashboard
• Fig. 31 Regional marketplace: Key takeaways
• Fig. 32 North America acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 33 US acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 34 Canada acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 35 Europe acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 36 UK acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 37 Germany acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 38 France acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 39 Italy acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 40 Spain acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 41 Asia Pacific acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 42 Japan acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 43 China acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 44 South Korea acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 45 Indonesia acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 46 Australia acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 47 India acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 48 Latin America acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 49 Brazil acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 50 Mexico acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 51 Argentina acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 52 Colombia acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 53 MEA acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 54 South Africa acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 55 Saudi Arabia acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 56 UAE acute external ventricular drain market, 2017 - 2030 (USD Million)
• Fig. 57 Company market share analysis, 2021
• Fig. 58 Market differentiators
• Fig. 59 Regional network map

Acute External Ventricular Drain Market Growth & Trends:

The global acute external ventricular drain market size is anticipated to reach USD 432.69 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.91% from 2022 to 2030. Rising adoption of conventional over the traditional method, increasing prevalence of acute hydrocephalus, and increasing adoption of technologically advanced devices for acute external ventricular drain are driving the industry's growth over the forecast period.

EVDs provide benefits for the treatment of acute hydrocephalus. Hydrocephalus is a medical emergency that requires the placement of an EVD into one of the brain's lateral ventricles to drain excess CSF. Each year, 740,000 instances of hydrocephalus in LMICs and about 30,000 in HICs require neurosurgery. Similarly, according to Hydrocephalus Association, hydrocephalus affects about 1 million Americans.

As per the same source, one in every 770 babies develops hydrocephalus in the U.S. Intraventricular hemorrhage is the most frequent cause of acquired hydrocephalus in babies, and studies have indicated that early intervention with an EVD (at the age of 25 days or younger) leads to improved neurological results. Since EVDs are most used in the abovementioned conditions, these factors have directly impacted the industry.

Furthermore, government initiatives such as grant allocation and approval, and investments to identify the most effective care and treatments to aid patient recovery after a brain injury are being implemented in various countries. According to the Hydrocephalus Association, approximately USD 12 million in research was invested in 2021, with an additional USD 35 million in federal funding provided for the study and development of hydrocephalus disease care in Canada.

Additionally, in April 2022, researchers were given a US 2.85 Mn NIH grant to explore a novel method for evaluating cerebrospinal fluid in infants with hydrocephalus. As a result of the aforementioned factors, the market is predicted to increase significantly in the near future.

Acute External Ventricular Drain Market Report Highlights:

• By application, Traumatic Brain Injury (TBI) accounted for the largest revenue share of 33.78% in 2021. This is due to the increasing prevalence of TBI along with an increase in the number of surgeries globally

• Based on patient type, the pediatric patient type segment is expected to grow at the fastest CAGR of 8.02% from 2022 to 2030,due to an increase in the number of surgical procedures to treat hydrocephalus in newborn babies. For instance, according to Pediatric Neurosurgery, approximately 69,000 hospital discharges of patients with hydrocephalus are reported each year in the U.S.

• Asia Pacificacute external ventricular drain market is expected to witness the fastest CAGR of 8.26% over the forecast period. This can be attributed to the increasing awareness and rising investment of key players in the developed and emerging nations, which are some of the major factors responsible for the significant growth rate during the forecast period

• The industry is highly competitive with players including Medtronic, Integra LifeSciences Corporation, Natus Medical Incorporated, Fuji Systems, Spiegelberg GmbH, SOPHYSA, and Neuromedex

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Application
  • 1.1.2 Patient Type
  • 1.1.3 Regional Scope
  • 1.1.4 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.6.2 Volume Price Analysis (Model 2)
    • 1.6.2.1 Approach 2: Volume price analysis
• 1.7 List of Secondary Sources
• 1.8 List of Primary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Acute External Ventricular Drain Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 User Perspective Analysis
  • 3.3.1 Consumer Behavior Analysis
  • 3.3.2 Market Influencer Analysis
• 3.4 List of Key End Users
• 3.5 Market Dynamics
  • 3.5.1 Market Driver Analysis
    • 3.5.1.1 Increasing prevalence of neurological disorders
    • 3.5.1.2 Rising burden of road accidents, falls, and sports injuries
    • 3.5.1.3 Rising awareness and demand for minimally invasive neurosurgical procedures
    • 3.5.1.4 Technological advancements
  • 3.5.2 Market Restraints Analysis
    • 3.5.2.1 Infections and complications caused due to external ventricular drain
    • 3.5.2.2 Lack of skilled professionals and access to ct scanners
  • 3.5.3 Market Opportunities Analysis
    • 3.5.3.1 Development of coated external ventricular drain
  • 3.5.4 Market Challenges Analysis
    • 3.5.4.1 Availability of alternatives to EVD
• 3.6 Acute External Ventricular Drain: Market Analysis Tools
  • 3.6.1 Industry Analysis - Porter's
  • 3.6.2 Swot Analysis, By Pest
• 3.7 Impact of COVID-19 on Market & Post Pandemic Insights

Chapter 4 Acute External Ventricular Drain Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Application Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Acute External Ventricular Drain Market, by Application, 2017 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
  • 4.5.1 Traumatic Brain Injury
    • 4.5.1.1 Traumatic brain injury market, 2017 - 2030 (USD Million)
  • 4.5.2 Subarachnoid Hemorrhage
    • 4.5.2.1 Subarachnoid hemorrhage market, 2017 - 2030 (USD Million)
  • 4.5.3 Intracerebral Hemorrhage
    • 4.5.3.1 Intracerebral hemorrhage market, 2017 - 2030 (USD Million)
  • 4.5.4 Other Non-Traumatic Hydrocephalus Conditions
    • 4.5.4.1 Other non-traumatic hydrocephalus conditions market, 2017 - 2030 (USD Million)

Chapter 5 Acute External Ventricular Drain Market: Segment Analysis, By Patient Type, 2017 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Patient Type Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Acute External Ventricular Drain Market, by Patient Type, 2017 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
  • 5.5.1 Pediatric
    • 5.5.1.1 Pediatric market, 2017 - 2030 (USD Million)
  • 5.5.2 Adult
    • 5.5.2.1 Adult market, 2017 - 2030 (USD Million)

Chapter 6 Acute External Ventricular Drain Market: Regional Market Analysis, By Application, and By Patient Type, 2017 - 2030 (USD Million)

• 6.1 Definition & Scope
• 6.2 Regional Market Share Analysis, 2021 & 2030
• 6.3 Regional Market Dashboard
• 6.4 Regional Market Snapshot
• 6.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
• 6.6 North America
  • 6.6.1 North America Acute External Ventricular Drain Market, 2017 - 2030 (USD Million)
  • 6.6.2 U.S.
    • 6.6.2.1 U.S. acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.6.3 Canada
    • 6.6.3.1 Canada acute external ventricular drain market, 2017 - 2030 (USD Million)
• 6.7 Europe
  • 6.7.1 Europe Acute External Ventricular Drain Market, 2017 - 2030 (USD Million)
  • 6.7.2 U.K.
    • 6.7.2.1 U.K. acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.7.3 Germany
    • 6.7.3.1 Germany acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.7.4 France
    • 6.7.4.1 France acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.7.5 Italy
    • 6.7.5.1 Italy acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.7.6 Spain
    • 6.7.6.1 Spain acute external ventricular drain market, 2017 - 2030 (USD Million)
• 6.8 Asia Pacific
  • 6.8.1 Asia Pacific Acute External Ventricular Drain Market, 2017 - 2030 (USD Million)
  • 6.8.2 Japan
    • 6.8.2.1 Japan acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.8.3 China
    • 6.8.3.1 China acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.8.4 India
    • 6.8.4.1 India acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.8.5 Australia
    • 6.8.5.1 Australia acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.8.6 South Korea
    • 6.8.6.1 South Korea acute external ventricular drain market, 2017 - 2030 (USD Million)
• 6.9 Latin America
  • 6.9.1 Latin America Acute External Ventricular Drain Market, 2017 - 2030 (USD Million)
  • 6.9.2 Brazil
    • 6.9.2.1 Brazil acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.9.3 Mexico
    • 6.9.3.1 Mexico acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.9.4 Argentina
    • 6.9.4.1 Argentina acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.9.5 Colombia
    • 6.9.5.1 Colombia acute external ventricular drain market, 2017 - 2030 (USD Million)
• 6.10 MEA
  • 6.10.1 MEA Acute External Ventricular Drain Market, 2017 - 2030 (USD Million)
  • 6.10.2 South Africa
    • 6.10.2.1 South Africa acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.10.3 Saudi Arabia
    • 6.10.3.1 Saudi Arabia acute external ventricular drain market, 2017 - 2030 (USD Million)
  • 6.10.4 UAE
    • 6.10.4.1 UAE acute external ventricular drain market, 2017 - 2030 (USD Million)

Chapter 7 Acute External Ventricular Drain Market - Competitive Analysis

• 7.1 Recent Developments & Impact Analysis, by Key Market Participants
• 7.2 Company Categorization
  • 7.2.1 Innovators
  • 7.2.2 Market Leaders
• 7.3 Vendor Landscape
  • 7.3.1 Key Company Market Share Analysis, 2021
  • 7.3.2 Major Deals And Strategic Alliances
    • 7.3.2.1 New Product Launch
    • 7.3.2.2 Expansion
    • 7.3.2.3 Acquisition
  • 7.3.3 Market Entry Strategies
• 7.4 Company Profiles
  • 7.4.1 MEDTRONIC
    • 7.4.1.1 Company overview
    • 7.4.1.2 Financial performance
    • 7.4.1.3 Product benchmarking
    • 7.4.1.4 Strategic initiatives
  • 7.4.2 NIPRO CORPORATION
    • 7.4.2.1 Company overview
    • 7.4.2.2 Financial performance
    • 7.4.2.3 Product benchmarking
    • 7.4.2.4 Strategic initiatives
  • 7.4.3 INTEGRA LIFESCIENCES CORPORATION
    • 7.4.3.1 Company overview
    • 7.4.3.2 Financial performance
    • 7.4.3.3 Product benchmarking
    • 7.4.3.4 Strategic initiatives
  • 7.4.4 NATUS MEDICAL INCORPORATED
    • 7.4.4.1 Company overview
    • 7.4.4.2 Financial performance
    • 7.4.4.3 Product benchmarking
    • 7.4.4.4 Strategic initiatives
  • 7.4.5 FUJI SYSTEMS
    • 7.4.5.1 Company overview
    • 7.4.5.2 Product benchmarking
    • 7.4.5.3 Strategic initiatives
  • 7.4.6 SPIEGELBERG GMBH
    • 7.4.6.1 Company overview
    • 7.4.6.2 Product benchmarking
    • 7.4.6.3 Strategic initiatives
  • 7.4.7 SOPHYSA
    • 7.4.7.1 Company overview
    • 7.4.7.2 Product benchmarking
    • 7.4.7.3 Strategic initiatives
  • 7.4.8 NEUROMEDEX
    • 7.4.8.1 Company overview
    • 7.4.8.2 Product benchmarking
    • 7.4.8.3 Strategic initiatives